Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Buy Biocon; target of Rs 340: Sharekhan

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 340 in its research report dated November 15, 2022.

November 21, 2022 / 03:09 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan's research report on Biocon

Biocon registered mixed operating performance in Q2 with revenue growing in strong double digits, while higher cost pressures led to a decline in PAT. Revenue grew by 26% y-o-y to Rs. 2,319.7 crore, driven by strong 34% y-o-y growth in the biologics segment, 25.9% y-o-y growth in the research services segment, and 17.5% y-o-y growth in the generic segment. EBIDTA margin fell by 399 BPS to 20.3%; PAT was down by 10% y-o-y to Rs. 205.7 crore. Consolidation of Viatris and the strategic vaccines alliance with Serum Institute will add to growth of the Biosimilars business in H2FY2023. Margins might remain lower due to higher R&D cost.

Outlook

The stock is currently trading at 32.9/21.6x its FY2023/FY2024E earnings. We maintain our Buy rating on the stock with a revised PT of Rs. 340.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Biocon - 21 -11-2022 - khan

Broker Research
first published: Nov 21, 2022 03:09 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347